Section 32 — 2020 Investments
4 investments dated 2020 · listed companies and verified rows first · show all
Aspen Neuroscience develops iPSC-derived autologous cell therapies for neurological diseases, with a lead product (ANPD001) in Phase 1/2a clinical trials for Parkinson's disease.
BiotechDeep TechDigital HealthMedical DevicesSan Diego, US
Andrés Bratt-Leal(Co-Founder and Senior Vice President, Research & Development)inANDRÉS BRATT-LEAL, Ph.D.(Co-Founder; Senior Vice President, Research & Development)Damien McDevitt(President and Chief Executive Officer)inDAMIEN MCDEVITT, Ph.D.(President and Chief Executive Officer)
Co-investorsARCH Venture PartnersLifeforce CapitalOrbiMedDomain AssociatesEDB InvestmentsFrazier Life Sciences+10 more
Cambridge, MA biotechnology company developing injectable synthetic biomarkers for noninvasive disease staging and treatment monitoring.
BiotechCambridge, US
Gabriel Kwong(Executive Officer)inSangeeta BhatiainRoopom Banerjee(Executive Officer)in
BoardTheresia Gouw(Director)inAmy Schulman(Director)Stan Lapidus(Director)in
Co-investorsCurious Office PartnersDallas Venture CapitalGreatPoint VenturesAcrew CapitalARCH Venture PartnersAspect Ventures+9 more
Prometheus uses solar and wind power to capture CO2 and water from the air and convert them into zero net carbon electrofuels—gasoline, diesel, and jet fuel that work in existing engines without modification.
Advanced ManufacturingCleantechClimate TechDeep TechEnergySanta Cruz, US
Rob McGinnis(CEO)inDr. Rob McGinnis(Founder & CEO)Seonah Jin(Senior Director of Engineering)
Co-investorsBMW i VenturesColor CapitalEmles Venture PartnersExpaMaersk GrowthMetaplanet+12 more
WithMe provides amenity solutions for multifamily properties and residential communities, featuring branded offerings like PrintWithMe for printing services and SipWithMe for beverage amenities.
CleantechConsumerHardwareImpact & Social GoodIoTPropTechSaaSChicago, US
Jonathan Treble(Founder)inWilliam A. Reid(Executive Officer)Jonathan Jenkins(Executive Officer, Director, Promoter)
BoardZach Ware(Director)inEric Salo(Director)Danielle Jenkins(Director)
Co-investorsGreat North VenturesOak HC/FTOMERS VenturesVTF Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.


























